Cited by 24Down syndrome and intellectual disability researchGenomic variations and chromosomal abnormalitiesGenetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities

Mouse models of aneuploidy to understand chromosome disorders

Open access
Tosh, Justin, Tybulewicz, Victor, Fisher, Elizabeth M. C.·2022·Mammalian Genome

Abstract

An organism or cell carrying a number of chromosomes that is not a multiple of the haploid count is in a state of aneuploidy. This condition results in significant changes in the level of expression of genes that are gained or lost from the aneuploid chromosome(s) and most cases in humans are not compatible with life. However, a few aneuploidies can lead to live births, typically associated with deleterious phenotypes. We do not understand why phenotypes arise from aneuploid syndromes in humans. Animal models have the potential to provide great insight, but less than a handful of mouse models of aneuploidy have been made, and no ideal system exists in which to study the effects of aneuploidy per se versus those of raised gene dosage. Here, we give an overview of human aneuploid syndromes, the effects on physiology of having an altered number of chromosomes and we present the currently available mouse models of aneuploidy, focusing on models of trisomy 21 (which causes Down syndrome) because this is the most common, and therefore, the most studied autosomal aneuploidy. Finally, we discuss the potential role of carrying an extra chromosome on aneuploid phenotypes, independent of changes in gene dosage, and methods by which this could be investigated further.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00335-021-09930-z

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mouse models have allowed advances in deciphering mechanisms governing brain development and function and the consequences of Down syndrome-related manipulations.

    “These models have allowed the scientific community to make incredible advances in deciphering the mechanisms governing brain development and function, as well as the consequences of DS-related manipulations for those mechanisms18–22.”

    From Consequences of trisomy 21 for brain development in Down syndrome (2024) · cites this paper as [21]

    The “Current mammalian models of aneuploidy” section (page unavailable) describes how Down syndrome mouse models reveal effects of gene-dosage manipulations on behaviour and cognition, supporting the brain-function portion of the claim. Our copy does not show that these models have deciphered mechanisms governing brain development; it also notes that existing models cannot isolate the effects of aneuploidy itself from gene dosage. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 75

  1. Ahmed MM Dhanasekaran AR Tong S Wiseman FK Fisher EMC Tybulewicz VLJ Gardiner KJ Protein profiles in Tc1 mice implicate novel pathway perturbations in the Down syndrome brain Hum Mol Genet 2013 22 9 1709 1724 10.1093/hmg/ddt017 23349361 PMC3613160 · DOI
  2. Antonarakis SE Petersen MB McInnis MG Adelsberger PA Schinzel AA Binkert F Hafez M The meiotic stage of nondisjunction in trisomy 21: determination by using DNA polymorphisms Am J Hum Genet 1992 50 3 544 550 1347192 PMC1684265
  3. Antonarakis SE Skotko BG Rafii MS Strydom A Pape SE Bianchi DW Reeves RH Down syndrome Nat Rev Dis Primers 2020 6 1 1 20 10.1038/s41572-019-0143-7 32029743 PMC8428796 · DOI · Paper page
  4. Ariyoshi K Miura T Kasai K Fujishima Y Oshimura M Yoshida MA Induction of genomic instability and activation of autophagy in artificial human aneuploid cells Mutat Res Fundam Mol Mech Mutagen 2016 790 19 30 10.1016/j.mrfmmm.2016.06.001 27343755 · DOI
  5. Ben-David U Arad G Weissbein U Mandefro B Maimon A Golan-Lev T Carlos Biancotti J Aneuploidy induces profound changes in gene expression, proliferation and tumorigenicity of human pluripotent stem cells Nat Commun 2014 5 4825 10.1038/ncomms5825 25198699 · DOI
  6. Benn P Trisomy 16 and trisomy 16 Mosaicism: a review Am J Med Genet 1998 79 2 121 133 10.1002/(SICI)1096-8628(19980901) 9741470 · DOI
  7. Berletch JB Yang F Xu J Carrel L Disteche CM Genes that escape from X inactivation Hum Genet 2011 130 2 237 245 10.1007/s00439-011-1011-z 21614513 PMC3136209 · DOI · Paper page
  8. Bolton H Graham SJL Van der Aa N Kumar P Theunis K Fernandez Gallardo E Zernicka-Goetz M Mouse model of chromosome mosaicism reveals lineage-specific depletion of aneuploid cells and normal developmental potential Nat Commun 2016 7 11165 10.1038/ncomms11165 27021558 PMC4820631 · DOI
  9. Bunnell ME Wilkins-Haug L Reiss R Should embryos with autosomal monosomy by preimplantation genetic testing for aneuploidy be transferred? Implications for embryo selection from a systematic literature review of autosomal monosomy survivors Prenat Diagn 2017 37 13 1273 1280 10.1002/pd.5185 29164644 · DOI
  10. Cereda A Carey JC The trisomy 18 syndrome Orphanet J Rare Dis 2012 7 1 1 10.1186/1750-1172-7-81 23088440 PMC3520824 · DOI
  11. Chunduri NK Storchová Z The diverse consequences of aneuploidy Nat Cell Biol 2019 21 1 54 62 10.1038/s41556-018-0243-8 30602769 · DOI
  12. Compton DA Mechanisms of aneuploidy Curr Opin Cell Biol 2011 23 1 109 113 10.1016/j.ceb.2010.08.007 20810265 PMC2997176 · DOI
  13. Costa ACS Stasko MR Schmidt C Davisson MT Behavioral validation of the Ts65Dn mouse model for Down syndrome of a genetic background free of the retinal degeneration mutation Pde6brd1 Behav Brain Res 2010 206 1 52 62 10.1016/j.bbr.2009.08.034 19720087 PMC2783207 · DOI
  14. Davisson MT Schmidt C Akeson EC Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome Prog Clin Biol Res 1990 360 263 280 2147289
  15. de Graaf G Buckley F Skotko BG Live births, natural losses and elective terminations with Down syndrome in Massachusetts Genet Med 2016 18 5 459 466 10.1038/gim.2016.15 27126496 · DOI
  16. Donnelly N Passerini V Dürrbaum M Stingele S Storchová Z HSF 1 deficiency and impaired HSP 90-dependent protein folding are hallmarks of aneuploid human cells EMBO J 2014 33 20 2374 2387 10.15252/embj.201488648 25205676 PMC4253526 · DOI
  17. Duchon A Raveau M Chevalier C Nalesso V Sharp AJ Herault Y Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling Down syndrome Mamm Genome 2011 22 11–12 674 684 10.1007/s00335-011-9356-0 21953411 PMC3224224 · DOI · Paper page
  18. Duchon A Del Mar Muniz Moreno M Martin Lorenzo S Silva de Souza MP Chevalier C Nalesso V Herault Y Multi-influential genetic interactions alter behaviour and cognition through six main biological cascades in Down syndrome mouse models Hum Mol Genet 2021 30 9 771 788 10.1093/hmg/ddab012 33693642 PMC8161522 · DOI
  19. Dunlevy L Bennett M Slender A Lana-Elola E Tybulewicz VL Fisher EMC Mohun T Down’s syndrome-like cardiac developmental defects in embryos of the transchromosomic Tc1 mouse Cardiovasc Res 2010 88 2 287 295 10.1093/cvr/cvq193 20558441 PMC2952533 · DOI
  20. Dürrbaum M Storchová Z Effects of aneuploidy on gene expression: Implications for cancer FEBS J 2016 283 5 791 802 10.1111/febs.13591 26555863 · DOI
  21. Eiben B Bartels I Bahr-Porsch S Borgmann S Gatz G Gellert G Hansmann I Cytogenetic analysis of 750 spontaneous abortions with the direct-preparation method of chorionic villi and its implications for studying genetic causes of pregnancy wastage Am J Hum Genet 1990 47 4 656 663 2220806 PMC1683793
  22. Forment JV Kaidi A Jackson SP Chromothripsis and cancer: causes and consequences of chromosome shattering Nat Rev Cancer 2012 12 10 663 670 10.1038/nrc3352 22972457 · DOI
  23. Fournier RE Ruddle FH Microcell-mediated transfer of murine chromosomes into mouse, Chinese hamster, and human somatic cells Proc Natl Acad Sci 1977 74 1 319 323 10.1073/pnas.74.1.319 264685 PMC393251 · DOI
  24. Gravholt CH Viuff MH Brun S Stochholm K Andersen NH Turner syndrome: mechanisms and management Nat Rev Endocrinol 2019 15 10 601 614 10.1038/s41574-019-0224-4 31213699 · DOI
  25. Gribble SM Wiseman FK Clayton S Prigmore E Langley E Yang F Carter NP Massively parallel sequencing reveals the complex structure of an irradiated human chromosome on a mouse background in the Tc1 model of Down syndrome PLoS ONE 2013 8 4 e60482 10.1371/journal.pone.0060482 23596509 PMC3626651 · DOI · Paper page
  26. Haas MA Bell D Slender A Lana-Elola E Watson-Scales S Fisher EMC Guillemot F Alterations to dendritic spine morphology, but not dendrite patterning, of cortical projection neurons in Tc1 and Ts1Rhr mouse models of Down syndrome PLoS ONE 2013 8 10 e78561 10.1371/journal.pone.0078561 24205261 PMC3813676 · DOI · Paper page
  27. Hall JH Wiseman FK Fisher EMC Tybulewicz VLJ Harwood JL Good MA Tc1 mouse model of trisomy-21 dissociates properties of short- and long-term recognition memory Neurobiol Learn Mem 2016 130 118 128 10.1016/j.nlm.2016.02.002 26868479 PMC4898594 · DOI
  28. Hassold T Hunt P To err (meiotically) is human: the genesis of human aneuploidy Nat Rev Genet 2001 2 4 280 291 10.1038/35066065 11283700 · DOI
  29. Hattori M Fujiyama A Taylor TD Watanabe H Yada T Park HS Yaspo ML The DNA sequence of human chromosome 21 Nature 2000 405 6784 311 319 10.1038/35012518 10830953 · DOI
  30. Herault Y Delabar JM Fisher EMC Tybulewicz VLJ Yu E Brault V Rodent models in Down syndrome research: impact and future opportunities Dis Model Mech 2017 10 10 1165 1186 10.1242/dmm.029728 28993310 PMC5665454 · DOI
  31. Hernandez D Mee PJ Martin JE Tybulewicz VL Fisher EM Transchromosomal mouse embryonic stem cell lines and chimeric mice that contain freely segregating segments of human chromosome 21 Hum Mol Genet 1999 8 5 923 933 10.1093/hmg/8.5.923 10196383 · DOI
  32. Hwang S Williams JF Kneissig M Lioudyno M Rivera I Helguera P Torres EM Suppressing aneuploidy-associated phenotypes improves the fitness of trisomy 21 cells Cell Rep 2019 29 8 2473 2488.e5 10.1016/j.celrep.2019.10.059 31747614 PMC6886690 · DOI
  33. Ishikawa K Makanae K Iwasaki S Ingolia NT Moriya H Post-translational dosage compensation buffers genetic perturbations to stoichiometry of protein complexes PLoS Genet 2017 13 1 1 22 10.1371/journal.pgen.1006554 PMC5266272 28121980 · DOI
  34. Kazuki Y Shinohara T Tomizuka K Katoh M Ohguma A Ishida I Oshimura M Germline transmission of a transferred human chromosome 21 fragment in transchromosomal mice J Hum Genet 2001 46 10 600 603 10.1007/s100380170028 11587075 · DOI
  35. Khan Z Ford MJ Cusanovich DA Mitrano A Pritchard JK Gilad Y Primate transcript and protein expression levels evolve under compensatory selection pressures Science (new York, N.y.) 2013 342 6162 1100 1104 10.1126/science.1242379 PMC3994702 24136357 · DOI · Paper page
  36. Kneissig M Keuper K de Pagter MS van Roosmalen MJ Martin J Otto H Storchova Z Micronuclei-based model system reveals functional consequences of chromothripsis in human cells Elife 2019 8 1 20 10.7554/eLife.50292 PMC6910827 31778112 · DOI
  37. Lana-Elola E Watson-Scales S Slender A Gibbins D Martineau A Douglas C Tybulewicz VL Genetic dissection of Down syndrome-associated congenital heart defects using a new mouse mapping panel Elife 2016 5 1 20 10.7554/eLife.11614 PMC4764572 26765563 · DOI
  38. Liu X Wu H Loring J Hormuzdi S Disteche CM Bornstein P Jaenisch R Trisomy eight in ES cells is a common potential problem in gene targeting and interferes with germ line transmission Dev Dyn 1997 209 1 85 91 10.1002/(SICI)1097-0177(199705)209:1<85::AID-AJA8>3.0.CO;2-T 9142498 · DOI
  39. Lugo TG Handelin B Killary AM Housman DE Fournier RE Isolation of microcell hybrid clones containing retroviral vector insertions into specific human chromosomes Mol Cell Biol 1987 7 8 2814 2820 10.1128/mcb.7.8.2814 2823107 PMC367898 · DOI
  40. McCarron M McCallion P Reilly E Dunne P Carroll R Mulryan N A prospective 20-year longitudinal follow-up of dementia in persons with Down syndrome J Intellect Disabil Res 2017 61 9 843 852 10.1111/jir.12390 28664561 · DOI · Paper page
  41. Migeon BR Pappas K Stetten G Trunca C Jacobs PA X inactivation in triploidy and trisomy: the search for autosomal transfactors that choose the active X Eur J Hum Genet EJHG 2008 16 2 153 162 10.1038/sj.ejhg.5201944 17971834 · DOI
  42. Mikwar M MacFarlane AJ Marchetti F Mechanisms of oocyte aneuploidy associated with advanced maternal age Mutat Res Rev Mutat Res 2020 785 108320 10.1016/j.mrrev.2020.108320 32800274 · DOI
  43. Mitchell LA Wang A Stracquadanio G Kuang Z Wang X Yang K Boeke JD Synthesis, debugging, and effects of synthetic chromosome consolidation: synVI and beyond Science 2017 10.1126/science.aaf4831 28280154 · DOI
  44. Morris JK Wald NJ Watt HC Fetal loss in Down syndrome pregnancies Prenat Diagn 1999 19 2 142 145 10.1002/(SICI)1097-0223(199902)19:2<142::AID-PD486>3.0.CO;2-7 10215072 · DOI
  45. Nagaoka SI Hassold TJ Hunt PA Human aneuploidy: mechanisms and new insights into an age-old problem Nat Rev Genet 2012 13 7 493 504 10.1038/nrg3245 22705668 PMC3551553 · DOI
  46. O’Doherty AM Fisher EMC Microcell-mediated chromosome transfer (MMCT): Small cells with huge potential Mamm Genome 2003 14 9 583 592 10.1007/s00335-003-4002-0 14629108 · DOI
  47. O’Doherty A Ruf S Mulligan C Hildreth V Errington ML Cooke S Fisher EMC An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes Science (new York, N.y.) 2005 309 5743 2033 2037 10.1126/science.1114535 PMC1378183 16179473 · DOI · Paper page
  48. Pai GS Lewandowski RC Borgaonkar DS Handbook of chromosomal syndromes 2003 Hoboken Wiley-Liss
  49. Passerini V Ozeri-Galai E De Pagter MS Donnelly N Schmalbrock S Kloosterman WP Storchová Z The presence of extra chromosomes leads to genomic instability Nat Commun 2016 10.1038/ncomms10754 26876972 PMC4756715 · DOI
  50. Poot M Hochstenbach R Prevalence and phenotypic impact of robertsonian translocations Mol Syndromol 2021 12 1 1 11 10.1159/000512676 33776621 PMC7983559 · DOI
  51. Pritchard MA Kola I The “gene dosage effect” hypothesis versus the “amplified developmental instability” hypothesis in Down syndrome J Neural Transm Suppl 1999 57 293 303 10666684
  52. Rasmussen SA Wong L-YC Yang Q May KM Friedman JM Population-based analyses of mortality in trisomy 13 and trisomy 18 Pediatrics 2003 111 4 Pt 1 777 784 10.1542/peds.111.4.777 12671111 · DOI
  53. Reeves RH Irving NG Moran TH Wohn A Kitt C Sisodia SS Davisson MT A mouse model for Down syndrome exhibits learning and behaviour deficits Nat Genet 1995 11 2 177 184 10.1038/ng1095-177 7550346 · DOI · Paper page
  54. Reinholdt LG Ding Y Gilbert GT Czechanski A Solzak JP Roper RJ Davisson MT Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn Mamm Genome 2011 22 11–12 685 691 10.1007/s00335-011-9357-z 21953412 PMC3505986 · DOI · Paper page
  55. Reynolds LE Watson AR Baker M Jones TA D’Amico G Robinson SD Hodivala-Dilke KM Tumour angiogenesis is reduced in the Tc1 mouse model of Down’s syndrome Nature 2010 465 7299 813 817 10.1038/nature09106 20535211 PMC3479956 · DOI
  56. Richardson SM Mitchell LA Stracquadanio G Yang K Dymond JS DiCarlo JE Bader JS Design of a synthetic yeast genome Science 2017 355 6329 1040 1044 10.1126/science.aaf4557 28280199 · DOI
  57. Rieseberg LH Willis JH Plant speciation Science (new York, N.y.) 2007 317 5840 910 914 10.1126/science.1137729 PMC2442920 17702935 · DOI · Paper page
  58. Root S Carey JC Survival in trisomy 18 Am J Med Genet 1994 49 2 170 174 10.1002/ajmg.1320490203 8116664 · DOI
  59. Sansregret L Swanton C The role of aneuploidy in cancer evolution Cold Spring Harb Perspect Med 2017 10.1101/cshperspect.a028373 28049655 PMC5204330 · DOI
  60. Segal DJ McCoy EE Studies on Down’s syndrome in tissue culture. I. Growth rates and protein contents of fibroblast cultures J Cell Physiol 1974 83 1 85 90 10.1002/jcp.1040830112 4273197 · DOI
  61. Shapiro BL The Down syndrome critical region J Neural Transm Suppl 1999 57 41 60 10.1007/978-3-7091-6380-1_3 10666667 · DOI
  62. Sheppard O Wiseman FK Ruparelia A Tybulewicz VLJ Fisher EMC Mouse models of aneuploidy Sci World J 2012 2012 214078 10.1100/2012/214078 PMC3259538 22262951 · DOI
  63. Shin M Siffel C Correa A Survival of children with mosaic Down syndrome Am J Med Genet A 2010 152 3 800 801 10.1002/ajmg.a.33295 20186777 · DOI
  64. Shinohara T Tomizuka K Takehara S Yamauchi K Katoh M Ohguma A Oshimura M Stability of transferred human chromosome fragments in cultured cells and in mice Chromosome Res 2000 8 8 713 725 10.1023/A:1026741321193 11196134 · DOI
  65. Skuse D Printzlau F Wolstencroft J Sex chromosome aneuploidies. Handbook of clinical neurology 2018 Amsterdam Elsevier 29325624
  66. Sparks TN Thao K Norton ME Mosaic trisomy 16: what are the obstetric and long-term childhood outcomes? Genet Med 2017 19 10 1164 1170 10.1038/gim.2017.23 28383546 PMC6029708 · DOI
  67. Stingele S Stoehr G Peplowska K Cox J Mann M Storchova Z Global analysis of genome, transcriptome and proteome reveals the response to aneuploidy in human cells Mol Syst Biol 2012 10.1038/msb.2012.40 22968442 PMC3472693 · DOI
  68. Thorpe J Osei-Owusu IA Avigdor BE Tupler R Pevsner J Mosaicism in human health and disease Annu Rev Genet 2020 54 487 510 10.1146/annurev-genet-041720-093403 32916079 PMC8483770 · DOI
  69. Tomizuka K Yoshida H Uejima H Kugoh H Sato K Ohguma A Ishida I Functional expression and germline transmission of a human chromosome fragment in chimaeric mice Nat Genet 1997 16 2 133 143 10.1038/ng0697-133 9171824 · DOI
  70. Torres EM Sokolsky T Tucker CM Chan LY Boselli M Dunham MJ Amon A Effects of aneuploidy on cellular physiology and cell division in haploid yeast Science 2007 317 5840 916 924 10.1126/science.1142210 17702937 · DOI · Paper page
  71. Torres EM Williams BR Amon A Aneuploidy: cells losing their balance Genetics 2008 179 2 737 746 10.1534/genetics.108.090878 18558649 PMC2429870 · DOI
  72. Williams BR Prabhu VR Hunter KE Glazier CM Whittaker CA Housman DE Amon A Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells Science 2008 322 5902 703 709 10.1126/science.1160058 18974345 PMC2701511 · DOI
  73. Wiseman FK Al-Janabi T Hardy J Karmiloff-Smith A Nizetic D Tybulewicz VLJ Strydom A A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome Nat Rev Neurosci 2015 16 1 11 10.1038/nrn3983 26243569 PMC4678594 · DOI · Paper page
  74. Witton J Padmashri R Zinyuk LE Popov VI Kraev I Line SJ Jones MW Hippocampal circuit dysfunction in the Tc1 mouse model of Down syndrome Nat Neurosci 2015 10.1038/nn.4072 26237367 PMC4552261 · DOI
  75. Zhang W Zhao G Luo Z Lin Y Wang L Guo Y Dai J Engineering the ribosomal DNA in a megabase synthetic chromosome Science 2017 10.1126/science.aaf3981 28280149 · DOI

Cited by

Sorted by citations

Authors
Tosh, J., Tybulewicz, V., & Fisher, E. M. C.
Affiliations
  • The Francis Crick Institute (GB)
  • UCL Queen Square Institute of Neurology (GB)
Corresponding author
Fisher, Elizabeth M. C.
Venue
Mammalian Genome
Published
2021-11-01
Volume
33
Issue
1
Pages
157-168
ISSN
  • 0938-8990 (ISSN-L)
  • 1432-1777
OpenAlex
W3210261625
Cited by
24
References
3
Citations by year
2026: 2 · 2025: 2 · 2024: 11 · 2023: 5 · 2022: 4
FWCI
0.89
Type
journal article
Language
en
Open access
Locations
  • Mammalian Genome (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Figshare (submittedVersion, cc-by)
  • The Francis Crick Institute (cc-by)
Funders
  • wellcome trust (098328, 098327, FC001194)
  • medical research council (U117527252, FC001194)
  • cancer research uk (FC001194)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
Keywords
aneuploidy, Down syndrome, gene dosage, chromosome number, autosomal aneuploidy
MeSH terms
Aneuploidy, Animals, Chromosomes, Disease Models, Animal, Down Syndrome, Trisomy, Chromosome Disorders, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review